Tech Company Financing Transactions
LifeSprout Funding Round
Redmile Group, Abell Venture Fund and Emerald Development Managers participated in a $28.5 million Series A capital raise for LifeSprout. The round was recorded on 4/28/2020.
Transaction Overview
Company Name
Announced On
4/28/2020
Transaction Type
Venture Equity
Amount
$28,500,000
Round
Series A
Investors
Proceeds Purpose
The company is using proceeds to support clinical development of novel therapeutic products from its Regenerative Matrix platform.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
1812 Ashland Ave. Ground Floor 100
Baltimore, MD 21205
USA
Baltimore, MD 21205
USA
Phone
Undisclosed
Website
Email Address
Overview
LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The company's Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the body's own tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Adam Gridley
Chief Executive Officer
Eric Goorno
Founder
Sashank Reddy
VP - General Counsel
Greg Sieczkiewicz
VP - Operations
Kevin Colbert
Browse more venture capital transactions:
Prev: 4/28/2020: Erasca venture capital transaction
Next: 4/28/2020: Rome Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record funding rounds that are announced publicly. All VC database entries on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs